1. Home
  2. IMUX vs PED Comparison

IMUX vs PED Comparison

Compare IMUX & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunic Inc.

IMUX

Immunic Inc.

BUY

Current Price

$6.93

Market Cap

155.8M

Sector

Health Care

ML Signal

BUY

Logo Pedevco Corp.

PED

Pedevco Corp.

SELL

Current Price

$13.06

Market Cap

179.0M

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
IMUX
PED
Founded
2016
N/A
Country
United States
United States
Employees
66
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
179.0M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
IMUX
PED
Price
$6.93
$13.06
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $43.09
N/A
AVG Volume (30 Days)
★ 415.4K
27.9K
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.00
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $45,751,000.00
Revenue This Year
N/A
$212.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 15.67
52 Week Low
$0.51
$8.64
52 Week High
$17.43
$133.98

Technical Indicators

Market Signals
Indicator
IMUX
PED
Relative Strength Index (RSI) 26.46 47.07
Support Level $0.83 $12.73
Resistance Level $15.82 $13.53
Average True Range (ATR) 0.67 0.54
MACD 0.00 -0.03
Stochastic Oscillator 15.06 38.25

Price Performance

Historical Comparison
IMUX
PED

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).

Share on Social Networks: